Home
Resources
Product Analysis
Acknowledgements
About
Products 51 to 60 of 323
Select one or more product filters to narrow matching products.
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
BIO-SA Based Solvents
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/09 16:31 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
BIO-SA Brand Flavor Enhancers
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2B
Country of production:
Canada
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:31 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
BIO-SA De-icing solutions
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
North America
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:26 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
BIO-SA Lubricant Additives and Base Stock
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2B
Country of production:
Canada
Country of distribution:
Canada
+
France
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:32 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
bioCement
by
bioMason
Biotech components:
Bacteria
Business models:
B2B
+
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:47 (6 years ago)
Known funding amount:
2,800,000 USD
Funding types:
Foundation
+
Government
+
University
+
Venture Capital
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Construction
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Biodata Tools/Medicine
by
Girihlet
Biotech components:
Gene Editing
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/28 16:57 (6 years ago)
Known funding amount:
250,000 USD
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
BioDirect Technology: RNAi pest control solution
by
Monsanto
Biotech components:
Enzyme
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
MON
(NYSE)
Value chain stage:
Finished Product
Bioengineered mRNA for gene therapy
by
University of Wisconin-Madison
Biotech components:
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:36 (4 years ago)
Date last modified:
2020/12/18 14:36 (4 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
N/A
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Platform
Bioengineered plant enzyme to speed up photosynthesis
by
Cornell University
Biotech components:
Enzyme
+
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:38 (4 years ago)
Date last modified:
2020/12/18 14:38 (4 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Plant
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Bioengineered Salmonella enterica
by
Prokarium
Biotech components:
Microbe
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:18 (5 years ago)
Date last modified:
2019/09/12 15:18 (5 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
1
2
3
4
5
6
7
8
9
10
…
33
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
